Searched for
MATRIX PHARMA
Kotak Alternate Asset Managers invests Rs 1,445 cr to help Matrix Pharma execute acquisitionKotak Alternate Asset Managers Ltd invested Rs 1,445 crore in Matrix Pharma for acquiring Vaitris' API business, making Matrix the 2nd larg...11 Jun, 2024, 09.41 PM IST- Edelweiss fund to back Matrix Lab founder's buyout of Viatris API bizKotak is lending $150 million (₹1,250 crore) under a mezzanine debt facility to Prasad at 18-20% and arranging an additional $300 million f...30 Apr, 2024, 05.48 AM IST
- SPARC, Sun Pharma climb on licensing agreementThe deal will make the company eligible for certain additional milestone payments and defined royalties linked to any future sales of ELEPS...18 Jul, 2016, 04.30 PM IST
- Hoffman La Roche loses patent suit against Matrix PharmaceuticalsRoche has lost a patent infringement suit against Matrix Pharma to prohibit the Indian firm from selling its anti-cancer drug Tarceva.14 Dec, 2011, 04.20 AM IST
- Mylan sells stake in Concord BiotechWorld’s second-largest generic drug maker Mylan, which held a majority stake in Ahmedabad-based Concord Biotech through its subsidiary Matr...08 Dec, 2009, 12.08 AM IST
- Matrix drags Israeli co Teva to court over patent issueThe dust hasn’t settled yet on the Novartis case and another patent dispute has emerged in the pharma space.10 Jul, 2009, 12.48 AM IST
- Merrill Lynch sells Rs 1.90-cr shares of Matrix LabsMerrill Lynch Capital Markets ESPANA has sold shares worth Rs 1.90 crore of the pharma company through an open market.17 Mar, 2009, 04.01 PM IST
- Masterminded Matrix Lab’s rise to the topThe first-generation entrepreneur who masterminded Matrix Lab’s rise to the top is now focusing his efforts on promoting entrepreneurship.21 Jul, 2007, 05.20 AM IST
- Cipla, Matrix tie up with Clinton FoundationIndian pharma companies have recorded one more international success. Domestic pharma companies Cipla and Matrix have entered into a tie-up...09 May, 2007, 02.22 AM IST
- Strides, Orchid may see stake rejigAfter the high-profile Mylan-Matrix deal, private equity firms are emerging as major catalysts in domestic pharma M&As.21 Sep, 2006, 12.26 AM IST
- Matrix founder Prasad set to get into the groove at MylanMatrix founder N Prasad, who has built an enterprise valued at $1bn in about five years, is in no mood to put his feet up and relax.09 Sep, 2006, 02.54 AM IST
- Matrix deal to trigger M&As in pharma secGlobal majors, Teva, Watson, Barr and Activis are also eyeing mid-sized and large Indian cos.30 Aug, 2006, 10.29 AM IST
- Global pharma cos may pop in buyout pillThe high-profile Mylan-Matrix deal is likely to trigger a series of mergers and acquisitions (M&A) in the Indian pharmaceutical market. Aro...30 Aug, 2006, 02.03 AM IST
- Mylan makes open offer for 20% stake in MatrixMP Laboratories (Mauritius) Ltd along with US-based generic pharma firm Mylan Laboratories Inc has issued an open offer to the shareholders...29 Aug, 2006, 06.50 PM IST
- US pharma major Mylan buys Matrix LabsThe generic drugs major will acquir Hyderabad-based Matix Lab in a cash-and-stock deal worth Rs 3,424 cr.29 Aug, 2006, 01.58 AM IST
- Mylan Labs to acquire 71.5% stake in MatrixIndian drug maker Matrix Laboratories Ltd on Monday said US-based generic pharma firm Mylan Laboratories Inc will acquire upto 71.5 per cen...28 Aug, 2006, 11.40 AM IST
- US' Mylan eyes MatrixUS-based Mylan Laboratories is believed to be in advanced talks with promoters and private equity funds to buy a majority stake in Matrix L...22 Jun, 2006, 02.02 AM IST
Load More
